<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9EF702DC-3E31-4C11-92D2-2FE8FBCA3235"><gtr:id>9EF702DC-3E31-4C11-92D2-2FE8FBCA3235</gtr:id><gtr:name>Chinese Academy of Agricultural Sciences</gtr:name><gtr:address><gtr:line1>Anyang</gtr:line1><gtr:postCode>455112</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8484BD99-7BD1-4B14-95B1-A3F33315CC68"><gtr:id>8484BD99-7BD1-4B14-95B1-A3F33315CC68</gtr:id><gtr:name>Chinese Center for Disease Control and Prevention (China CDC)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9EF702DC-3E31-4C11-92D2-2FE8FBCA3235"><gtr:id>9EF702DC-3E31-4C11-92D2-2FE8FBCA3235</gtr:id><gtr:name>Chinese Academy of Agricultural Sciences</gtr:name><gtr:address><gtr:line1>Anyang</gtr:line1><gtr:postCode>455112</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8484BD99-7BD1-4B14-95B1-A3F33315CC68"><gtr:id>8484BD99-7BD1-4B14-95B1-A3F33315CC68</gtr:id><gtr:name>Chinese Center for Disease Control and Prevention (China CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0E155302-1387-442D-98C3-7A782273607F"><gtr:id>0E155302-1387-442D-98C3-7A782273607F</gtr:id><gtr:firstName>Xiao-Ning</gtr:firstName><gtr:surname>Xu</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1001047"><gtr:id>B56E2CB1-0F50-4274-91ED-8E09054A9A94</gtr:id><gtr:title>The study of efficacy and immune correlates to an inactivated H5N1 vaccine in non-human primates</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001047</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The highly pathogenic strains of avian influenza (H5N1) virus from Asia, which have a near 50% death rate in infected humans, pose a potential threat to the public health should they start transmitting between humans. An effective vaccine that induces a long-lasting protective immunity against this virus is urgently needed. However, our knowledge of the mechanism governing protective immunity to influenza A virus is incomplete, particularly the immunogenicity of avian influenza virus in humans. The aim of this proposal, involving collaboration with two Chinese research institutes, is to study the efficacy and protective immunity of an inactivated H5N1 vaccine in non-human primates. Our results will provide novel and invaluable information for designing safe and cost-effective vaccines for future pandemic influenza</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>153452</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Academy of Agricultural Sciences</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Harbin Veterinary Research Institute (HVRI)</gtr:department><gtr:description>Avian Flu vaccine -NHP</gtr:description><gtr:id>0091A3C8-4BA0-4118-B953-994373E35682</gtr:id><gtr:impact>One publication</gtr:impact><gtr:partnerContribution>vaccine development and animal model</gtr:partnerContribution><gtr:piContribution>Antibody and T cell responses</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Center for Disease Control and Prevention (China CDC)</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Influenza infection and vaccine</gtr:description><gtr:id>54CA6163-2CE3-4C20-8CC6-3EFFC64D8626</gtr:id><gtr:impact>two publications</gtr:impact><gtr:partnerContribution>organising cohort studies</gtr:partnerContribution><gtr:piContribution>performing T cell responses</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/355060DB-E894-48A7-AA6D-224F04B807D4"><gtr:id>355060DB-E894-48A7-AA6D-224F04B807D4</gtr:id><gtr:title>Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6728b659ca9047957546c2994120446a"><gtr:id>6728b659ca9047957546c2994120446a</gtr:id><gtr:otherNames>Wilkinson TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE4C3667-4C5E-44D8-BC70-1D0DCD44E782"><gtr:id>FE4C3667-4C5E-44D8-BC70-1D0DCD44E782</gtr:id><gtr:title>Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14bc14b523f46259b756e82875d7f82"><gtr:id>c14bc14b523f46259b756e82875d7f82</gtr:id><gtr:otherNames>Liu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F67AD44-171B-4EF9-97E0-AF48DBFCB1BF"><gtr:id>3F67AD44-171B-4EF9-97E0-AF48DBFCB1BF</gtr:id><gtr:title>Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3eae989d7fe2595c2c6dea57f94ec9e5"><gtr:id>3eae989d7fe2595c2c6dea57f94ec9e5</gtr:id><gtr:otherNames>Wu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2DEF720-4F9F-434C-BBEB-5A237ACC6EFD"><gtr:id>F2DEF720-4F9F-434C-BBEB-5A237ACC6EFD</gtr:id><gtr:title>Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed8abc0535485a4ce59719db1a799a06"><gtr:id>ed8abc0535485a4ce59719db1a799a06</gtr:id><gtr:otherNames>Shu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/04C35FCF-442F-48BF-86CE-E5F4424675EA"><gtr:id>04C35FCF-442F-48BF-86CE-E5F4424675EA</gtr:id><gtr:title>Correlates of protection against influenza infection in humans--on the path to a universal vaccine?</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75748a5e143534eedf92ee65231cd08e"><gtr:id>75748a5e143534eedf92ee65231cd08e</gtr:id><gtr:otherNames>Li CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001047</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>